Form 4: Volcon CFO Greg Endo Reports Significant Stock and Option Acquisitions
Beneficial Ownership Statement
Volcon, Inc.'s Chief Financial Officer, Greg Endo, reported the acquisition of 20,000 common shares in a private placement and new stock option grants totaling over 800,000 shares, with vesting tied to stock price performance and subject to shareholder approval.
Summary
- Greg Endo, Volcon, Inc.'s Chief Financial Officer, acquired 20,000 shares of common stock at $10 per share on July 21, 2025, as part of a private placement with accredited and institutional investors.
- An existing option grant for 72,150 shares was amended on July 17, 2025, increasing the exercise price to $10 per share. These options were adjusted for a one-for-eight reverse stock split on June 11, 2025, and were granted in connection with employment service.
- Greg Endo was granted an additional 747,005 stock options on July 17, 2025, with vesting tied to the stock's Volume Weighted Average Price (VWAP), starting at 20% vesting upon the VWAP reaching $10 and fully vesting upon a VWAP of $30.
- All vesting of the 747,005 stock options is contingent upon the approval of a new stock option plan by Volcon's stockholders.
Sentiment
Score: 7
Explanation: The filing indicates strong insider confidence through a direct share purchase and the implementation of performance-based stock options with ambitious price targets, aligning management incentives with significant shareholder value creation. However, the contingency of stockholder approval for the new option plan and the prior reverse stock split introduce some caution.
Positives
- CFO Greg Endo's direct purchase of 20,000 shares at $10 indicates management confidence in the company's valuation and future prospects.
- The grant of 747,005 performance-based stock options aligns the CFO's incentives directly with shareholder value creation, as vesting is tied to significant stock price appreciation targets up to $30 VWAP.
Negatives
- The amendment to an existing option grant increased the exercise price to $10 per share, which could be perceived as less favorable for the option holder compared to a lower exercise price.
- The vesting of the substantial 747,005 stock options is subject to stockholder approval of a new stock option plan, introducing a contingency that could delay or prevent the full realization of these incentives.
Risks
- The vesting of 747,005 stock options granted to the CFO is contingent upon stockholder approval of a new stock option plan, introducing uncertainty regarding the full implementation of these executive incentives.
- The performance-based vesting of 747,005 stock options relies on the company's common stock reaching specific Volume Weighted Average Price (VWAP) targets ($10 and $30), indicating market performance risk for the full realization of these options.
Future Outlook
The vesting of 747,005 stock options is tied to future stock price performance, with full vesting contingent on the stock's Volume Weighted Average Price reaching $30, indicating a long-term growth outlook for the company's share value. All vesting is subject to future stockholder approval of a new stock option plan.
Management Comments
- The shares of common stock were purchased by the Reporting Person in the Issuer's recently announced private placement with certain accredited and institutional investors, which closed on July 21, 2025.
- The Reporting Person and the Issuer amended an existing option grant agreement pursuant to which the Reporting Person was granted options to purchase 72,150 shares of common stock of the Issuer (as adjusted for the Issuer's June 11, 2025 one-for-eight reverse stock split) in connection with the Reporting Person's employment service to the Company. The amendment increased the exercise price of such options to $10 per share of common stock.
- The stock options vest based upon the daily volume weighted average price ("VWAP") of the Issuer's common stock, vesting as to 20% of the of the underlying shares of common stock upon the VWAP reaching $10 and then in incremental 20% installments until becoming fully vested upon a VWAP of $30. All vesting is subject to the approval by the Issuer's stockholders of a new stock option plan.
- The stock options were issued by the Issuer in connection with the Reporting Person's employment service as Chief Financial Officer of the Issuer on July 17, 2025. All vesting is subject to the approval by the Issuer's stockholders of a new stock option plan.
Industry Context
This filing reflects standard executive compensation practices and insider trading disclosures common in publicly traded companies, particularly those undergoing capital raises (private placement) and implementing performance-based incentive plans to align management interests with shareholder returns. The prior reverse stock split indicates a company that may have been addressing a low share price, and the new options with higher strike prices suggest a renewed focus on increasing share value.
Comparison to Industry Standards
- The private placement at $10 per share is a specific transaction and cannot be directly compared to industry standards without knowing the company's market capitalization, recent trading prices, and the terms of other recent private placements in similar-sized companies within the electric powersports or light electric vehicle industry.
- Performance-based stock options tied to VWAP targets (e.g., $10, $30) are a common incentive mechanism in growth-oriented companies, aligning executive compensation with significant share price appreciation. This structure is comparable to similar plans seen in technology or emerging market companies where substantial growth is anticipated.
- The one-for-eight reverse stock split on June 11, 2025, is a common corporate action for companies seeking to increase their share price to meet exchange listing requirements or improve market perception, a practice observed across various industries for companies with low stock prices.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Stock Option Plan Approval | Vesting of 747,005 stock options is subject to the approval by the Issuer's stockholders of a new stock option plan. | NA | This indicates a future corporate governance action required to fully implement the executive compensation structure, potentially impacting shareholder voting and dilution. |
Stakeholder Impact
- Shareholders: Potential dilution from new stock option grants (747,005 shares) if the new stock option plan is approved. Alignment of CFO incentives with shareholder value through performance-based vesting. The private placement indicates new institutional investment.
- Employees: The options are granted in connection with employment service, which is a form of compensation.
Next Steps
- Stockholder approval of a new stock option plan is required for the vesting of 747,005 stock options granted to the CFO.
Key Dates
| Date | Description |
|---|---|
| 05/30/2025 | Date exercisable for 72,150 stock options. |
| 06/11/2025 | Effective date of Volcon's one-for-eight reverse stock split. |
| 07/17/2025 | Date of earliest transaction; amendment of existing option grant and grant of new stock options to Greg Endo. |
| 07/21/2025 | Date of common stock purchase by Greg Endo in a private placement. |
| 05/30/2035 | Expiration date for 72,150 stock options. |
| 07/17/2035 | Expiration date for 747,005 stock options. |
Recommendation
holdKeywords
Volcon Inc., VLCN, SEC Form 4, Beneficial Ownership, Insider Trading, Greg Endo, Chief Financial Officer, Stock Options, Private Placement, Equity Acquisition, Performance-Based Vesting, Reverse Stock Split, Corporate Governance, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.